Opendata, web and dolomites

The MATRIX SIGNED

Inflammatory resolution and remodelling of the adipose extracellular matrix: key determinants of a metabolically healthy phenotype?

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 The MATRIX project word cloud

Explore the words cloud of the The MATRIX project. It provides you a very rough idea of what is the project "The MATRIX" about.

cell    individuals    obese    comorbidities    molecular    inflammatory    understand    urgently    protein    pipelines    lab    that    metabolically    fingerprints    clinical    mhl    me    affiliated    mho    metabolite    trials    healthy    ultimately    pro    candidate    techniques    differentiate    inflammation    certain    remodelling    disease    halt    followed    metabolic    matrix    critical    drug    drugs    edge    tackle    subgroups    attempting    hypothesise    therapeutic    separates    endogenous    right    appears    lean    biobanks    lipids    human    resolve    anti    biology    lines    ex    phenotypes    specialised    groups    reduce    generate    vivo    serious    data    extracellular    placement    appear    economic    obesity    consists    limited    patient    site    socio    public    translational    driver    distinguishes    switch    regulated    unhealthy    cutting    triggers    coupled    diabetes    bioinformatics    lipid    preliminary    disciplinary    respective    pose    muo    resolving    adipose    combines    diseases    health    cells    protected    burden    mul   

Project "The MATRIX" data sheet

The following table provides information about the project.

Coordinator
GOETEBORGS UNIVERSITET 

Organization address
address: VASAPARKEN
city: GOETEBORG
postcode: 405 30
website: www.gu.se

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Total cost 1˙700˙002 €
 EC max contribution 1˙700˙002 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2018-STG
 Funding Scheme ERC-STG
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2024-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GOETEBORGS UNIVERSITET SE (GOETEBORG) coordinator 1˙700˙002.00

Map

 Project objective

Obesity and its affiliated metabolic diseases pose serious public-health challenges. However, certain patient subgroups appear protected. To halt the socio-economic burden of metabolic disease, we urgently need to understand what distinguishes the Metabolically-Healthy-Lean (MHL), Metabolically-Unhealthy-Lean (MUL), Metabolically-Healthy-Obese (MHO) and Metabolically-Unhealthy-Obese (MUO) phenotypes, and which factors promote metabolic health. Inflammation has been proposed as a target, as it is a key driver of metabolic disease. However, clinical trials show limited evidence that anti-inflammatory drugs reduce diabetes. Why is that?

Inflammation consists of a pro-inflammatory phase followed by a pro-resolving phase, which are regulated by different cells/pathways. This is critical to consider when attempting a therapeutic approach. Based on my preliminary data, I hypothesise that what separates MHL/MHO from MUL/MUO are not pro-inflammatory triggers, but rather the endogenous ability of individuals to resolve inflammation. Adipose extracellular-matrix remodelling appears critical, and pro-resolving lipids promote a MUO-to-MHO switch.

My overall goal is to determine molecular pathways that differentiate the MHL/MUL/MHO/MUO phenotypes (Aim 1-4), and to investigate the therapeutic potential of pro-resolving lipids (Aim 5). This multi-disciplinary project combines cutting-edge techniques with state-of-the-art translational approaches. Through my unique access to human biobanks, I will generate patient-specific cell-lines and test drug-targets ex vivo. Novel bioinformatics pipelines will produce protein/lipid/metabolite fingerprints associated with respective patient groups, ultimately providing a new approach to tackle obesity-related comorbidities. My experience in the specialised field of pro-resolving lipid biology, coupled with my lab’s unique placement at a translational site, makes me the right candidate to lead this research program.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "THE MATRIX" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "THE MATRIX" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

DOUBLE-TROUBLE (2020)

Replaying the ‘genome duplication’ tape of life: the importance of polyploidy for adaptation in a changing environment

Read More  

E-DIRECT (2020)

Evolution of Direct Reciprocity in Complex Environments

Read More  

TORYD (2020)

TOpological many-body states with ultracold RYDberg atoms

Read More